Boji Medical Technology Co Ltd
SZSE:300404

Watchlist Manager
Boji Medical Technology Co Ltd Logo
Boji Medical Technology Co Ltd
SZSE:300404
Watchlist
Price: 8.69 CNY -6.16% Market Closed
Market Cap: 3.3B CNY
Have any thoughts about
Boji Medical Technology Co Ltd?
Write Note

Net Margin
Boji Medical Technology Co Ltd

5.5%
Current
8%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.5%
=
Net Income
36.9m
/
Revenue
664.9m

Net Margin Across Competitors

Country CN
Market Cap 3.3B CNY
Net Margin
6%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 196.3B USD
Net Margin
14%
Country US
Market Cap 170.3B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 36.7B USD
Net Margin
9%
Country US
Market Cap 26.4B USD
Net Margin
21%
Country US
Market Cap 23B USD
Net Margin
17%
Country US
Market Cap 22.3B USD
Net Margin
-36%
No Stocks Found

Boji Medical Technology Co Ltd
Glance View

Market Cap
3.3B CNY
Industry
Life Sciences Tools & Services

Boji Medical Technology Co., Ltd. is a contract research organization(CRO) that offers outsourcing drugs research and development services, including new drugs evaluation and clinical trials, preclinical studies and researches, medical devices registration, data management, biostatistics and other consultation services. The company is headquartered in Guangzhou, Guangdong and currently employs 989 full-time employees. The company went IPO on 2015-04-24. The firm mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The firm's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The firm mainly conducts its businesses in the domestic market.

Intrinsic Value
9.32 CNY
Undervaluation 7%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.5%
=
Net Income
36.9m
/
Revenue
664.9m
What is the Net Margin of Boji Medical Technology Co Ltd?

Based on Boji Medical Technology Co Ltd's most recent financial statements, the company has Net Margin of 5.5%.